The genetics of Alzheimer disease: Current status and future prospects

Archives of Neurology

Volumn 55, Issue 3, 1998, Pages 294-296

  Blacker, Deborah ^a,b   Tanzi, Rudolph E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; CHROMOSOME 21; FAMILY HISTORY; GENETIC ANALYSIS; GENETIC RISK; GENETICS; HUMAN; MOLECULAR GENETICS; PENETRANCE; PREDICTION; PRIORITY JOURNAL; STEM CELL;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; HUMANS; MEMBRANE PROTEINS; PRESENILIN-1; PRESENILIN-2;

EID: 0031918785     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.55.3.294     Document Type: Article

References (27)

1. Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a novel gene bearing missense mutations in early familial Alzheimer disease. Nature. 1995;375:754-760.
2. Levy-Lehad E, Wasco W, Poorkaj P, et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 1995;269:973-977.
3. Goate AM, Chartier-Harlin MC, Mullan MC, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 1991;349:704-706.
4. Strittmatter WJ, Saunders AM, Schnechel D, et al. Apolipoprotein E: high avidity binding to b-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 1993;90:1977-1981.
5. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993;43:1467-1472.
6. Farrer LA, Myers RH, Cupples LA, et al. Transmission and age-at-onset patterns in familial Alzheimer's disease: evidence for heterogeneity. Neurology. 1990;38:395-403.
7. Bergem AL, Engedal K, Kringlen EL. The role of heredity in late-onset Alzheimer disease and vascular dementia: a twin study. Arch Gen Psychiatry. 1997;54:264-270.
8. Lautenschlager NT, Cupples LA, Rao VS, et al. Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: what is in store for the oldest old? Neurology. 1996;46:641-650.
9. Tanzi RE, Gusella JF, Watkins PC, et al. Amyloid β protein gene: cDNA, mRNA distribution and genetic linkage near the Alzheimer locus. Science. 1987;235:880-884.
10. Tanzi RE, Kovacs DM, Kim T-W, Moir RD, Guenette SY, Wasco W. The gene defects responsible for familial Alzheimer's disease. Neurobiol Dis. 1996;3:159-168.
11. Sorbi S, Nacmias B, Forleo P, Piancentini S, Latorraca S, Amaducci L. Epistatic effect of APP717 mutation and apolipoprotein E genotype in familial Alzheimer's disease. Ann Neurol. 1993;38:124-127.
12. Schellenberg GD, Bird TD, Wijsman EM, et al. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science. 1992;258:668-671.
13. Van Broeckhoven C, Backhovens H, Cruts M, et al. APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease. Neurosci Lett. 1994;169:179-180.
14. Bird TD, Levy-Lahad E, Poorkaj P, et al. Wide range in age of onset for chromosome 1-related familial Alzheimer's disease. Ann Neurol. 1996;40:932-936.
15. Sherrington R, Froelich S, Sorbi S, et al. Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant. Hum Mol Genet. 1996;5:985-988.
16. Schellenberg GD. Genetic dissection of Alzheimer disease, a heterogeneous disorder. Proc Natl Acad Sci U S A. 1995;92:8552-8559.
17. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late-onset Alzheimer disease. Nat Genet. 1994;7:180-184.
18. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late-onset families. Science. 1993;261:921-923.
19. Locke P, Conneally PM, Tanzi RE, et al. APOE and Alzheimer disease: examination of allelic association and effect on age at onset in both early- and late-onset cases. Genet Epidemiol. 1995;12:83-92.
20. Blacker D, Haines JL, Rodes L, et al. APOE-4 and age-at-onset of Alzheimer's disease: the NIMH Genetics Initiative. Neurology. 1997;48:139-147.
21. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer's Disease. Statement on use of apolipoprotein E testing for Alzheimer's disease. JAMA. 1995;274:1627-1629.
22. National Institute on Aging/Alzheimer's Association Working Group. Apolipoprotein E genotyping in Alzheimer's disease. Lancet 1996;347:1091-1095
23. Games D, Adams D, Alessandrini R, et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature. 1995;373:523-527.
24. Hsiao K, Chapman P, Nilsen S, et al. Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice. Science. 1996;274:99-102.
25. Scheuner D, Eckman C, Jensen M, et al. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med. 1996;2:864-870.
26. Hyman BT, West HL, Rebeck GW, et al. Quantitative analysis of senile plaques in Alzheimer's disease: observation of log-normal size distribution and molecular epidemiology of differences associated with ApoE genotype and trisomy 21 (Down syndrome). Proc Natl Acad Sci U S A. 1995;92:3586-3590.
27. Kim T-W, Pettingell WH, Jung YK, Kovacs DM, Tanzi RE. Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science. 1997;277:373-376.